Abnormal Temporal Slowing on EEG Findings in Preclinical Alzheimer’s Disease Patients With the ApoE4 Allele: A Pilot Study

Introduction: Currently, there are limited accessible and cost-effective biomarkers for preclinical Alzheimer’s disease (AD) patients. However, the apolipoprotein E (ApoE) polymorphic alleles can predict if someone is at high (e4), neutral (e3), or low (e2) genetic risk for developing AD. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Nathan N, Tan, Charissa, Ma, Enze, Kutlu, Selin, Carrazana, Enrique, Vimala, Vajjhala, Viereck, Jason, Liow, Kore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679961/
https://www.ncbi.nlm.nih.gov/pubmed/38021568
http://dx.doi.org/10.7759/cureus.47852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679961/
https://www.ncbi.nlm.nih.gov/pubmed/38021568
http://dx.doi.org/10.7759/cureus.47852

Ejemplares similares